{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:56:30Z","timestamp":1761101790715},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T00:00:00Z","timestamp":1132704000000},"content-version":"vor","delay-in-days":9092,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1981,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical response to levamisole in 11 patients with complete Behcet's syndrome was reviewed. Nine patients responded, 3 completely and 6 partially, with reduction in the number and severity of buccal and genital lesions. In 3 patients each, ocular inflammation and gastrointestinal involvement responded to levamisole, and in 1 patient neurologic status improved. Levamisole was purposely discontinued in 3 patients to assess its true role in disease control. Each patient experienced a flare. Reintroduction of therapy controlled the flare in all cases, although 1 patient subsequently relapsed while continuing therapy. Two patients failed to respond. Side effects necessitated permanent discontinuation of the drug in 2 respondent patients, but in no case did neutropenia or agranulocytosis develop. These preliminary results suggest that levamisole may be useful in the therapy of the various manifestations of Behcet's syndrome and that a controlled prospective study is indicated.<\/jats:p>","DOI":"10.1002\/art.1780240111","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T19:28:35Z","timestamp":1171481315000},"page":"64-70","source":"Crossref","is-referenced-by-count":37,"title":["Treatment of behcet's syndrome with levamisole"],"prefix":"10.1002","volume":"24","author":[{"given":"Paula","family":"De Merieux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E","family":"Spitler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold E","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(79)90004-0"},{"key":"e_1_2_1_3_2","first-page":"972","article-title":"Behcet's syndrome","volume":"29","author":"Wright V","year":"1978","journal-title":"Bull Rheum Dis"},{"key":"e_1_2_1_4_2","first-page":"229","article-title":"Summary of International Symposium on Behcet's disease","volume":"5","author":"O'Duffy JD","year":"1978","journal-title":"J Rheumatol"},{"key":"e_1_2_1_5_2","first-page":"345","article-title":"Behcet's Syndrome Workshop.","volume":"10","author":"Aphthous Stomatitis.","year":"1978","journal-title":"J Oral Pathol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5538.465"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(69)90174-5"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(73)90077-4"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1974.01630030021003"},{"key":"e_1_2_1_10_2","first-page":"234","article-title":"Reduction of complement in Behcet's disease and drug allergy","volume":"52","author":"Shimada K","year":"1974","journal-title":"Med Biol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6073.1387"},{"key":"e_1_2_1_12_2","first-page":"409","article-title":"Behcet's disease:possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease","volume":"91","author":"Abdou N","year":"1978","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_13_2","first-page":"193","article-title":"Circulating soluble immune complexes in recurrent oral ulceration and Behcet's syndrome","volume":"32","author":"Levinsky RJ","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_14_2","first-page":"213","article-title":"Circulating immune complexes in active Behcet's disease","volume":"34","author":"Gupta RC","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_15_2","first-page":"206","article-title":"Damaged membrane fragments and immune complexes in the blood of patients with Behcet's syndrome","volume":"34","author":"Lehner T","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90461-3"},{"key":"e_1_2_1_17_2","first-page":"175","article-title":"Levamisole in the modulation of the immune response:the current experimental and clinical state","volume":"21","author":"Symoens J","year":"1977","journal-title":"J Reticuloendothel Soc"},{"issue":"4","key":"e_1_2_1_18_2","volume":"5","author":"Proceedings of the Symposium on Levamisole in Rheumatoid Arthritis","year":"1978","journal-title":"J Rheumatol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)90879-9"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5944.592"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(76)90311-X"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90891-6"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6062.671"},{"key":"e_1_2_1_24_2","first-page":"119","volume-title":"Drugs and Immune Responses.","author":"Lehner T","year":"1978"},{"key":"e_1_2_1_25_2","first-page":"278","article-title":"Levamisole and skin disease","volume":"17","author":"Allen DE","year":"1978","journal-title":"Int J Biochem"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1978.tb01606.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.28.2.95"},{"key":"e_1_2_1_28_2","first-page":"291","article-title":"Editorial: Behcet's","volume":"18","author":"Japanese Committee on Behcet's Disease","year":"1974","journal-title":"Jap J Ophthalmol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(56)91461-1"},{"key":"e_1_2_1_30_2","first-page":"69","article-title":"Behcet's disease:presentation of eleven cases and evaluation of treatment","volume":"2","author":"Haim S","year":"1966","journal-title":"Isr J Med Sci"},{"key":"e_1_2_1_31_2","first-page":"469","article-title":"Behcet's disease","volume":"40","author":"Misra MP","year":"1963","journal-title":"J Indian Med Assoc"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(62)90411-7"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-75-4-561"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90166-2"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000305426"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8707(69)90148-8"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1970.00990040448008"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.57.9.706"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1969.00990010630006"},{"key":"e_1_2_1_40_2","first-page":"1421","article-title":"Results of immunosuppressive treatment in Behcet's disease","volume":"10","author":"Firat T","year":"1978","journal-title":"Ann Ophthal"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197505000-00001"},{"key":"e_1_2_1_42_2","unstructured":"BernhardGC GoldmanA KozinF NelmL:Further observations on the treatment of Behcet's disease and transfer factor. XIV International Congress of Rheumatology San Francisco June\u2010July1977(abstract #902)"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.238.8.869"},{"key":"e_1_2_1_44_2","unstructured":"O'DuffyJ:Prognostic features in Behcet's disease.XIV International Congress of Rheumatology San Francisco June\u2010July1977(abstract #923)"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780240111","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780240111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T20:03:39Z","timestamp":1700769819000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780240111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1981,1]]}},"alternative-id":["10.1002\/art.1780240111"],"URL":"https:\/\/doi.org\/10.1002\/art.1780240111","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,1]]}}}